U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Orange Book Home

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 214801

LYTGOBI (FUTIBATINIB)
4MG
Marketing Status: Prescription
Active Ingredient: FUTIBATINIB
Proprietary Name: LYTGOBI
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 4MG
Reference Listed Drug: Yes
Reference Standard: Yes
TE Code: 
Application Number: N214801
Product Number: 001
Approval Date: Sep 30, 2022
Applicant Holder Full Name: TAIHO ONCOLOGY INC
Marketing Status:  Prescription
Patent and Exclusivity Information
Back to Top